Gensight Biologics SA is a clinical-stage biotechnology group discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PNQI | 50.41 | 0.58 | +1.16% |
| Invesco NASDAQ Internet ETF | |||
| VOOV | 185.06 | 1.88 | +1.03% |
| Vanguard S&P 500 Value ETF | |||
| BKIV | 35.94 | 0.27 | +0.74% |
| BNY Mellon Innovators ETF | |||
| HAWX | 35.10 | 0.18 | +0.51% |
| iShares Currency Hdgd MSCI ACWI exUS ETF | |||
| FTRI | 13.94 | -0.03 | -0.21% |
| First Trust Indxx Glbl Natrl Res Inc ETF | |||
A.I.dvisor indicates that over the last year, GSGTF has been loosely correlated with HRTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GSGTF jumps, then HRTX could also see price increases.
| Ticker / NAME | Correlation To GSGTF | 1D Price Change % | ||
|---|---|---|---|---|
| GSGTF | 100% | N/A | ||
| HRTX - GSGTF | 45% Loosely correlated | +5.00% | ||
| RPTX - GSGTF | 34% Loosely correlated | -1.34% | ||
| GOSS - GSGTF | 30% Poorly correlated | +5.56% | ||
| BVAXF - GSGTF | 29% Poorly correlated | N/A | ||
| SPRC - GSGTF | 29% Poorly correlated | -1.88% | ||
More | ||||